Cerebral blood flow is thought to increase at high altitude and in subjects suffering from acute mountain sickness (AMS); however, data from the literature are contentious. Blood flow velocity in the middle cerebral artery (MCAv) may be used as a proxy measure of cerebral blood flow. Using transcranial Doppler sonography, MCAv was measured during normo- and hyper-ventilation in subjects who participated in a trial that tested the effect of magnesium supplementation on the prevention of AMS. First, MCAv was recorded at 353 m (baseline). Subjects were then randomized to receive oral magnesium citrate and matching placebo. A second measurement was taken after a 24±2 h ascent from 1130 m to 4559 m (altitude I), and a third after a 20–24 h stay at 4559 m (altitude II). Using multivariate linear regression, an association was sought between MCAv and magnesium supplementation, subjects′ age and gender, altitude itself, a temporary stay at altitude, and the presence of AMS (Lake Louise Score >6 with ataxia, nausea and/or headache). Subjects with AMS had additional Doppler recordings immediately before and after rescue medication (oxygen, dexamethasone and acetazolamide). Forty-seven subjects had measurements at baseline, 39 (21 receiving magnesium and 18 placebo) at altitude I and 26 (13 receiving magnesium and 13 placebo) at altitude II. During hyperventilation, MCAv decreased consistently (for each measurement, P<0.001). Magnesium significantly increased MCAv by 8.4 cm·s-1 (95% confidence interval, 1.8–15), but did not prevent AMS. No other factors were associated with MCAv. Eleven subjects had severe AMS [median score (range), 11 (8–16)] and, after rescue medication, the median score decreased to 3 (range, 0–5; P=0.001), but MCAv remained unchanged (65±18 cm·s-1 before compared with 67±16 cm·s-1 after rescue medication; P=0.79). MCAv was increased in subjects who received magnesium, but was not affected by exposure to high altitude or by severe AMS.
Skip Nav Destination
Article navigation
Research Article|
March 01 2004
Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery Available to Purchase
Christopher LYSAKOWSKI;
*Neuroanaesthesia Unit, Division of Anaesthesiology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospitals, Geneva, Switzerland
Correspondence: Dr Christopher Lysakowski (e-mail [email protected]).
Search for other works by this author on:
Erik VON ELM;
Erik VON ELM
†Perioperative Evidence-Based Medicine Program, Division of Anaesthesiology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospitals, Geneva, Switzerland
Search for other works by this author on:
Lionel DUMONT;
Lionel DUMONT
*Neuroanaesthesia Unit, Division of Anaesthesiology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospitals, Geneva, Switzerland
Search for other works by this author on:
Jean-Daniel JUNOD;
Jean-Daniel JUNOD
*Neuroanaesthesia Unit, Division of Anaesthesiology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospitals, Geneva, Switzerland
Search for other works by this author on:
Edömer TASSONYI;
Edömer TASSONYI
*Neuroanaesthesia Unit, Division of Anaesthesiology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospitals, Geneva, Switzerland
Search for other works by this author on:
Bengt KAYSER;
Bengt KAYSER
‡Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other works by this author on:
Martin R. TRAMÈR
Martin R. TRAMÈR
*Neuroanaesthesia Unit, Division of Anaesthesiology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospitals, Geneva, Switzerland
†Perioperative Evidence-Based Medicine Program, Division of Anaesthesiology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, Geneva University Hospitals, Geneva, Switzerland
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
May 27 2003
Revision Received:
September 24 2003
Accepted:
October 22 2003
Accepted Manuscript online:
October 22 2003
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2004 The Biochemical Society
2004
Clin Sci (Lond) (2004) 106 (3): 279–285.
Article history
Received:
May 27 2003
Revision Received:
September 24 2003
Accepted:
October 22 2003
Accepted Manuscript online:
October 22 2003
Citation
Christopher LYSAKOWSKI, Erik VON ELM, Lionel DUMONT, Jean-Daniel JUNOD, Edömer TASSONYI, Bengt KAYSER, Martin R. TRAMÈR; Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery. Clin Sci (Lond) 1 March 2004; 106 (3): 279–285. doi: https://doi.org/10.1042/CS20030188
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |